/LOVE.V
LOVE.V Stock - Cannara Biotech Inc.
Healthcare|Drug Manufacturers - Specialty & GenericTSXV
$1.71-2.84%
$0.05 (-2.84%) • Dec 22
70
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.63
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $1.88
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for LOVE.V
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$1.69 – $1.73
TARGET (TP)$1.97
STOP LOSS$1.57
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.32
52W High$1.99
52W Low$0.69
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $107.32M | $81.75M | $57.26M | $35.84M | $17.02M |
| Gross Profit | $47.22M | $29.79M | $27.23M | $17.33M | $10.30M |
| Gross Margin | 44.0% | 36.4% | 47.6% | 48.4% | 60.5% |
| Operating Income | $22.20M | $10.08M | $11.89M | $3.67M | $192,597 |
| Net Income | $13.08M | $6.44M | $6.95M | $2.31M | $-3,094,350 |
| Net Margin | 12.2% | 7.9% | 12.1% | 6.4% | -18.2% |
| EPS | $0.14 | $0.07 | $0.08 | $0.03 | $-0.04 |
Company Overview
Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivated products in Canada. It also offers hemp-based CBD products through e-commerce platform. The company was incorporated in 2017 and is headquartered in Saint-Laurent, Canada.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
LOVE.VBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$0.04
Q4 2025
EPS Surprise History
Q2 24
No data
Q3 24
No data
Q4 24
No data
Q1 25
No data
Q2 25
No data
Q3 25
No data
Q3 25
No data
Q4 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 27, 2026 | — | — | — | — |
Q4 2025 | Nov 24, 2025 | — | $0.04 | — | — |
Q3 2025 | Jul 28, 2025 | — | $0.04 | — | — |
Q3 2025 | Jul 24, 2025 | — | $0.04 | — | — |
Q2 2025 | Apr 28, 2025 | — | $0.04 | — | — |
Q1 2025 | Jan 27, 2025 | — | $0.03 | — | — |
Q4 2024 | Nov 25, 2024 | — | $0.02 | — | — |
Q3 2024 | Jul 23, 2024 | — | $0.02 | — | — |
Q2 2024 | Apr 29, 2024 | — | $-0.04 | — | — |
Q1 2024 | Jan 29, 2024 | — | $0.02 | — | — |
Q4 2023 | Nov 24, 2023 | — | $0.05 | — | — |
Q3 2023 | Jul 27, 2023 | — | $0.03 | — | — |
Q2 2023 | May 4, 2023 | — | $-0.01 | — | — |
Q1 2023 | Jan 23, 2023 | — | $0.00 | — | — |
Q4 2022 | Nov 25, 2022 | — | $0.02 | — | — |
Q3 2022 | Aug 31, 2022 | — | $0.03 | — | — |
Q1 2022 | Feb 28, 2022 | — | $-0.02 | — | — |
Q4 2021 | Nov 30, 2021 | — | $-0.01 | — | — |
Q3 2021 | Aug 31, 2021 | — | $0.01 | — | — |
Q2 2021 | May 31, 2021 | — | $0.02 | — | — |
Latest News
Loading news...
Frequently Asked Questions about LOVE.V
What is LOVE.V's current stock price?
Cannara Biotech Inc. (LOVE.V) is currently trading at $1.71 per share. The stock has moved -2.84% today.
What is the analyst price target for LOVE.V?
No analyst price targets are currently available for this stock.
What sector is Cannara Biotech Inc. in?
Cannara Biotech Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the TSXV exchange.
What is LOVE.V's market cap?
Cannara Biotech Inc. has a market capitalization of $0.16 billion, making it a small-cap company.
Does LOVE.V pay dividends?
No, Cannara Biotech Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorCRDL.TO
Cardiol Therapeutics Inc.
$1.40
Mkt Cap: $0.1B
DB.V
Decibel Cannabis Company Inc.
$0.10
Mkt Cap: $0.1B
GRIN.CN
Grown Rogue International Inc.
$0.57
Mkt Cap: $0.1B
HBP.TO
Helix BioPharma Corp.
$2.29
Mkt Cap: $0.2B
HLS.TO
HLS Therapeutics Inc.
$4.75
Mkt Cap: $0.1B
JUSH.CN
Jushi Holdings Inc.
$0.76
Mkt Cap: $0.1B
MSCL.TO
Satellos Bioscience Inc.
$0.66
Mkt Cap: $0.1B
QIPT.TO
Quipt Home Medical Corp.
$4.84
Mkt Cap: $0.2B
RX.V
BioSyent Inc.
$12.30
Mkt Cap: $0.1B
XLY.TO
Auxly Cannabis Group Inc.
$0.15
Mkt Cap: $0.2B
Explore stocks similar to LOVE.V for comparison